Part of this company’s product portfolio is a unique and groundbreaking digital PCR technology. 5AM was brought in to support customer adoption and significant operational improvements around the customization of the laboratory validated assays. The most prominent applications include copy number variation (CNV), rare mutations and gene expression. While they had an in-house assay design pipeline solution, they lacked the mechanisms to operationalize this service. The company partnered with 5AM to devise a strategy and collaboratively develop a web interface for customers to design and purchase those assays through the corporation’s e-commerce system. Launch was announced April 25, 2016 and can be reviewed at

Previous Post

Boehringer Ingelheim: Patient Data Sharing through Blockchain

1 comment

  1. Hi, this is a comment.
    To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
    Commenter avatars come from Gravatar.

Scroll to top